Independent comparisons. Transparent pricing. Commercial relationships cannot buy a better ranking.

RightFit Health

How Much Does Sermorelin Cost Through Telehealth?

Current program pricing, prepaid discounts, fees, and formulation differences for sermorelin.

Updated 9/25/2026 · Verified 9/25/2026

Direct answer

Telehealth sermorelin pricing varies by formulation, provider, and plan length. RightFit’s current research includes month-to-month compounded injection programs, lower multi-month equivalents, a compounded orally dissolving formulation, quarterly billing, and programs with separate memberships. The useful comparison is therefore the exact formulation plus the normal recurring price, required fees, commitment, and what the provider includes.

Current sermorelin price snapshot

Current sermorelin price snapshot

Providers tracked11
Programs tracked12
Standard price range$129 – $239

Tracked sermorelin pricing

Tracked sermorelin pricing

ProviderProgramFormPublished priceTermsVerified
IViM Health**Visit provider ↗Compounded SermorelinCompoundedinjection · subcutaneous
$129 / monthStandard · Current product-page price.Separate $75/month IViM membership shown on current Sermorelin page.Source ↗
See provider detailsSep 24, 2026Program source ↗
10RxVisit provider ↗SermorelinCompoundedinjection · subcutaneous
$172.96 / monthStandard · Quarterly-plan monthly equivalent; provider displays $518.87 billed today.Medication, provider evaluation, and delivery are included.Source ↗
Current catalog offeringSep 24, 2026Program source ↗
Shed / ShedRxVisit provider ↗SermorelinCompoundedinjection · subcutaneous
$199 / monthStandard · Sermorelin injection monthly priceSource ↗
See provider detailsSep 24, 2026Program source ↗
EffectyVisit provider ↗SermorelinCompoundedinjection · subcutaneous
$200 / monthPromotional · Longer-term listed rateLower rate shown for multi-month purchase.Source ↗
$225 / monthStandard · MonthlySource ↗
See provider detailsSep 24, 2026Program source ↗
BelleVisit provider ↗SermorelinCompoundedinjection · subcutaneous
$119 / monthPromotional · Three-month plan effective monthly amountThree-month plan.Source ↗
Three-month program displayedSep 24, 2026Program source ↗
Yucca HealthVisit provider ↗SermorelinCompoundedinjection · subcutaneous
$158 / monthPromotional · Three-month plan effective monthly amount$475 billed every 3 months.Source ↗
$199 / monthStandard · Monthly planSource ↗
Monthly and 3-month plans shownSep 24, 2026Program source ↗
NavioMD**Visit provider ↗SermorelinCompoundedinjection · subcutaneous
$135 / monthStandard · Current product-page priceRequired prescription and 2-day shipping described on current page.Source ↗
Plan selected at checkoutSep 24, 2026Program source ↗
TRAVAVisit provider ↗SermorelinCompoundedinjection · subcutaneous
$157.91 / monthStandard · 3mg displayed monthly priceSource ↗
Monthly pricing displayed; quarterly package promotedSep 24, 2026Program source ↗
Zappy Health**Visit provider ↗SermorelinCompoundedinjection · subcutaneous
$239 / monthStandard · Current monthly subscription price; all doses.Provider page shows monthly virtual visits, AI assistant access and premium support.Source ↗
See provider detailsSep 24, 2026Program source ↗
Gimme CareVisit provider ↗Sermorelin InjectionCompoundedinjection · subcutaneous
$179 / monthPromotional · Three-month effective monthly amountThree-month billing cycle.Source ↗
$189 / monthStandard · Month-to-monthSource ↗
Monthly and 3-month plans shownSep 24, 2026Program source ↗
AmbleVisit provider ↗Sermorelin InjectionCompoundedinjection · subcutaneous
$135 / monthPromotional · Six-month effective monthly amountSix-month plan.Source ↗
$149 / monthPromotional · Three-month effective monthly amountThree-month plan.Source ↗
$159 / monthStandard · One-month planSource ↗
1, 3 and 6 month plans displayedSep 24, 2026Program source ↗
EffectyVisit provider ↗Sermorelin ODTCompoundedODT · oral
$170 / monthPromotional · Longer-term listed rateLower rate shown for multi-month purchase.Source ↗
$190 / monthStandard · MonthlySource ↗
See provider detailsSep 24, 2026Program source ↗

** State availability: Availability varies by state and treatment. Providers marked ** do not offer every program in all 50 states. Verify availability directly with the provider before enrolling.

The lowest monthly equivalent often requires a longer term

Several providers publish lower effective monthly sermorelin rates for three- or six-month plans. Amble currently shows a one-month price and lower three- and six-month equivalents. Yucca Health publishes month-to-month and three-month structures. Belle and Gimme Care also publish multi-month pricing in the current research set.

Those discounted monthly amounts should not replace the ordinary monthly rate because the customer is committing to a different billing structure.

Quarterly billing can look monthly in an advertisement

10Rx’s current sermorelin program illustrates another structure: the provider displays a monthly equivalent while the program is billed as a quarterly package. RightFit preserves both the monthly equivalent and the amount/term billed so a quarterly plan is not mistaken for monthly billing.

Membership fees can sit outside the medication price

IViM Health currently publishes a sermorelin product price while a separate recurring membership applies. In that structure, the medication amount is not the full recurring program cost.

Other providers include membership or clinical access in the displayed price. RightFit does not force those models into one medication number.

Injection and ODT prices are not directly interchangeable

The current catalog includes compounded sermorelin injections and an orally dissolving tablet program. Those routes should remain separate when interpreting price. A lower ODT price or injection price does not establish that the products are clinically equivalent or interchangeable.

Shipping can be included without every other service being included

Several provider rows explicitly include shipping with the sermorelin program. That does not prove labs, memberships, or every follow-up service are included. Each inclusion is stored independently when the provider source supports it.

Unknown lab costs remain unknown

Many current provider pages do not publish one universal lab requirement or fee for sermorelin. RightFit leaves the lab field unresolved instead of assuming testing is free or unnecessary.

Historical FDA context should not be used as a pricing shortcut

FDA records document historical approval of Geref (sermorelin acetate) for a pediatric growth-hormone-deficiency indication. The current RightFit telehealth rows are compounded programs and should not be described as FDA-approved Geref products merely because they use sermorelin acetate.

That regulatory distinction does not directly set the price, but it prevents an older approved product identity from being used to imply that current compounded telehealth programs are the same commercial product.

Why provider wellness claims do not belong in the price calculation

Providers can advertise sermorelin around sleep, recovery, body composition, or other outcomes. Those claims are separate from the verified commercial facts. RightFit can compare what the provider charges and includes without treating the marketing claims as established benefits.

How to calculate a practical recurring cost

Start with the normal recurring price for the exact sermorelin formulation. Add any verified required membership or care fee for the same period. Then note whether shipping is included and whether the customer must prepay several months to obtain a lower effective rate.

Do not add a speculative lab or fee

If the provider does not clearly publish a lab charge, membership, or other required amount, RightFit leaves it unverified rather than inventing a total.

What to compare before enrolling

  • Exact formulation and route
  • Normal month-to-month or recurring price
  • Lower multi-month or promotional price
  • Amount and term paid up front
  • Required membership or subscription fee
  • Whether provider review and shipping are included
  • Whether labs are included, separate, or unverified
  • Cancellation and renewal terms
  • Current source and verification date

Why a low prepaid rate is not automatically the cheapest practical plan

A multi-month discount can reduce the effective monthly price while increasing the amount committed before the customer knows whether the treatment plan will remain unchanged. The commercial tradeoff is price versus flexibility, not a simple better-versus-worse ranking.

Why the current table needs periodic re-verification

Compounded telehealth pricing can change when providers update pharmacies, supply amounts, memberships, or plan lengths. A provider can leave the product name unchanged while materially changing the recurring cost. Verification dates make those changes visible.

What the price comparison cannot decide

A lower sermorelin price cannot determine whether sermorelin is appropriate for an individual, whether one formulation is preferable, or whether a provider’s marketing claims apply. Prescribing and monitoring decisions belong to licensed healthcare professionals.

A published starting price can describe several different situations

A sermorelin page may show a normal month-to-month amount, a lower effective price for a longer commitment, an introductory promotion, or a landing-page offer that is not the same as the provider’s main treatment catalog. Those figures should not be collapsed into one “current price.” RightFit stores the pricing condition with the observation so a starting amount does not become a universal recurring rate.

This is particularly important when a provider publishes more than one first-party page. If the pages disagree, the correct response is to identify the conflict, determine whether one figure is promotional, and keep the ordinary commercial terms separate rather than simply selecting the cheaper number.

The route can change what the price represents

Most current telehealth sermorelin programs in RightFit are modeled as compounded injections, but the catalog also includes an orally dissolving formulation. The price of an ODT program should not be used to estimate the cost of an injection program, and an injection price should not be treated as a market-wide sermorelin price without labeling the route.

Route also affects the commercial package a provider may advertise, including supply format, shipping, and how the program is described. RightFit keeps those product details attached to each provider-treatment row so a lower price remains tied to the formulation that actually carries it.

The best cost comparison separates recurring cost from cash due today

A customer evaluating a three-, six-, or twelve-month plan needs two numbers: the effective monthly rate and the actual amount committed or billed for the plan. A lower monthly equivalent can still require substantially more money at enrollment than a flexible monthly option.

RightFit therefore does not use the lowest effective monthly figure alone to label one plan cheaper. The billing cadence, term, and upfront obligation remain visible so readers can compare cash flow as well as the normalized monthly amount.

What a complete cost record should contain

  • Exact sermorelin formulation and route.
  • Normal recurring medication or program amount.
  • Promotional or prepaid effective monthly amount, if any.
  • Required commitment and amount billed for that commitment.
  • Separate membership, care, or subscription fee.
  • Shipping inclusion when the provider confirms it.
  • Lab cost or requirement only when verified.
  • Cancellation and renewal terms when published.
  • Provider-primary source and last-verification date.

If one of those fields is not public, leaving it unknown is more accurate than completing the total with an assumption. That approach makes the price table slightly less tidy, but substantially more trustworthy.

Bottom line

Current telehealth sermorelin pricing is best understood as a set of provider-specific compounded programs with different formulations and billing terms. RightFit keeps normal and prepaid prices, memberships, inclusions, and historical FDA context separate so the comparison explains the commercial offer without turning price or marketing claims into a treatment recommendation.